Home・Akcijų sąrašas・Compugen Ltd

Compugen Ltd

Uždarymo kaina

2.31 -2.53

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.31

Max

2.39

Pagrindiniai rodikliai
By Trading Economics
Pajamos	663K -7M
Pardavimai	426K 2.6M
P/E Sektoriaus vid.	6.324 57.002
Pelnas, tenkantis vienai akcijai	-0.07
Pelno marža	-269.254
Darbuotojai	75
EBITDA	665K -7M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+112.77% upside

Dividendai
By Acuity
Kitas uždarbis	2026-11-09

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-3.8M 221M
Ankstesnė atidarymo kaina	4.84
Ankstesnė uždarymo kaina	2.31

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-17 23:57; UTC

Ambarella shares declined during after-market hours amid broader geopolitical concerns affecting market sentiment. The stock remained above its 20-day moving average.

2026-08-17 23:56; UTC

Correlated Moves

Energy Fuels Inc. shares rose in after-market trading amid positive sentiment in the energy sector and rising crude oil prices due to geopolitical tensions.

2026-08-17 23:56; UTC

Insteel Industries Inc shares are lower in after-market hours, following a slight decline after Monday's close amid broader market geopolitical concerns.

2026-08-17 23:56; UTC

Correlated Moves

Valley National Bancorp shares are trading higher in after-market hours, reflecting stability as they remain near the upper end of their one-month range.

2026-08-17 23:56; UTC

Shares of Aquestive Therapeutics Inc. are trading higher in after-market hours, remaining significantly above their 20-day moving average. No specific news was identified.

2026-08-17 23:56; UTC

Social Media

Immunovant shares are higher in after-market trading, driven by positive sentiment around the product pipeline for IMVT-1402 and comparisons to ARGX's success.

2026-08-17 23:56; UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

2026-08-17 23:56; UTC

Brown & Brown Inc. shares are trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower and remaining below the 20-day moving average.

2026-08-17 23:56; UTC

iHeartMedia Inc shares are higher in after-market trading, recovering from earlier declines amid geopolitical concerns and rising crude oil prices.

2026-08-17 23:56; UTC

Clean Harbors Inc. shares are higher in after-market trading, reflecting a modest gain since Monday's close amid rising crude oil prices and geopolitical tensions.

2026-08-17 23:56; UTC

ETF Constituents

Correlated Moves

Macro News

Boston Properties announced a $700 million public offering of senior unsecured notes due in 2036, funding existing debt repayment. VNQ remains roughly flat in after-market trading.

2026-08-17 23:56; UTC

Mondelez International Inc. is seeing modest gains in after-market trading. Broader market dynamics have influenced trading activity today, but no specific news was identified.

2026-08-17 23:56; UTC

Correlated Moves

Eastman Chemical Co shares are lower in after-market hours amid market volatility and rising crude oil prices, influenced by geopolitical tensions in the Middle East.

2026-08-17 23:56; UTC

Oil States International shares rise in after-market hours, supported by increasing Brent crude prices, which reached $90.68 amid Middle East geopolitical tensions.

2026-08-17 23:56; UTC

Sabre Corp shares are lower in after-market trading, amid notable volatility and broader market concerns over escalating geopolitical tensions and rising crude oil prices.

2026-08-17 23:56; UTC

Correlated Moves

Northern Oil and Gas Inc remains roughly flat in after-market trading amid geopolitical concerns affecting oil prices, which saw a slight uptick.

2026-08-17 23:56; UTC

News

Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

2026-08-17 23:56; UTC

Accuray Inc shares are lower in after-market trading amid broader market fluctuations and geopolitical concerns, though they remain above their 20-day moving average.

2026-08-17 23:56; UTC

United Airlines shares advanced in after-market trading, reflecting a modest rise despite geopolitical concerns and rising crude oil prices impacting operational costs.

2026-08-17 23:56; UTC

Correlated Moves

Flowers Foods Inc remains roughly flat in after-market trading amid broader market movements influenced by escalating geopolitical tensions in the Middle East.

2026-08-17 23:56; UTC

Transocean Ltd shares are higher in after-market trading, supported by rising crude oil prices amid geopolitical tensions affecting shipping routes.

2026-08-17 23:56; UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

2026-08-17 23:56; UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

2026-08-17 23:56; UTC

Williams Companies shares are higher in after-market trading, supported by rising crude oil prices amid geopolitical tensions in the Middle East.

2026-08-17 23:56; UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

2026-08-17 23:56; UTC

Albany International shares declined in after-market hours amid broader market weakness. The stock remains below its 20-day moving average and near its one-month low.

2026-08-17 23:56; UTC

Array Technologies shares are higher in after-market hours, despite trading below their 20-day moving average amid broader market dynamics and geopolitical tensions.

2026-08-17 23:56; UTC

Correlated Moves

Macro News

Crude oil prices increased amid escalating tensions in the Middle East, influencing broader market volatility. The US 30Y Treasury Bond Index is trading slightly higher.

2026-08-17 23:52; UTC

Fifth Third Bancorp shares are lower in after-market trading amid rising geopolitical tensions and increasing crude oil prices, with no specific company news identified.

2026-08-17 23:52; UTC

Australia's Consumer Confidence Data Release Set for August 18 Amidst Fragile Economic Sentiment and High Inflation Concerns.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

112.77% į viršų

12 mėnesių prognozė

Vidutinis 5 USD 112.77%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Compugen Ltd akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.